HLA-G and neoplasm: Substantial previous evidence has proved that HLA-G is a crucial tumor-driven immune escape factor involved in alterating the anti-tumor responses of immune contexture of solid tumors like CRC, and thus in determination of the fate of tumor development and patient clinical outcome (1).